These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 19123050

  • 1. MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents.
    Woodahl EL, Crouthamel MH, Bui T, Shen DD, Ho RJ.
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):183-8. PubMed ID: 19123050
    [Abstract] [Full Text] [Related]

  • 2. MDR1 G1199A polymorphism alters permeability of HIV protease inhibitors across P-glycoprotein-expressing epithelial cells.
    Woodahl EL, Yang Z, Bui T, Shen DD, Ho RJ.
    AIDS; 2005 Oct 14; 19(15):1617-25. PubMed ID: 16184031
    [Abstract] [Full Text] [Related]

  • 3. Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein.
    Woodahl EL, Yang Z, Bui T, Shen DD, Ho RJ.
    J Pharmacol Exp Ther; 2004 Sep 14; 310(3):1199-207. PubMed ID: 15100388
    [Abstract] [Full Text] [Related]

  • 4. Impacts of ABCB1 (G1199A) polymorphism on resistance, uptake, and efflux to steroid drugs.
    Peng R, Zhang H, Zhang Y, Wei DY.
    Xenobiotica; 2016 Oct 14; 46(10):948-52. PubMed ID: 26822676
    [Abstract] [Full Text] [Related]

  • 5. A novel human multidrug resistance gene MDR1 variant G571A (G191R) modulates cancer drug resistance and efflux transport.
    Yang Z, Wu D, Bui T, Ho RJ.
    J Pharmacol Exp Ther; 2008 Nov 14; 327(2):474-81. PubMed ID: 18723777
    [Abstract] [Full Text] [Related]

  • 6. ABCB1 1199G>A Polymorphism Affects the Intracellular Accumulation of Antidepressants in LLC-PK1 Recombinant Cell Lines.
    Gao YL, He B.
    DNA Cell Biol; 2018 Dec 14; 37(12):1055-1060. PubMed ID: 30256659
    [Abstract] [Full Text] [Related]

  • 7. Effects of MDR1 (C3435T) Polymorphism on Resistance, Uptake, and Efflux to Antiepileptic Drugs.
    Shen XM, Cheng J.
    DNA Cell Biol; 2019 Mar 14; 38(3):250-255. PubMed ID: 30632789
    [Abstract] [Full Text] [Related]

  • 8. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells.
    Salama NN, Yang Z, Bui T, Ho RJ.
    J Pharm Sci; 2006 Oct 14; 95(10):2293-308. PubMed ID: 16883550
    [Abstract] [Full Text] [Related]

  • 9. MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer.
    Fung KL, Pan J, Ohnuma S, Lund PE, Pixley JN, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM.
    Cancer Res; 2014 Jan 15; 74(2):598-608. PubMed ID: 24305879
    [Abstract] [Full Text] [Related]

  • 10. Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells.
    Mutoh K, Tsukahara S, Mitsuhashi J, Katayama K, Sugimoto Y.
    Cancer Sci; 2006 Nov 15; 97(11):1198-204. PubMed ID: 16925584
    [Abstract] [Full Text] [Related]

  • 11. MDR1 C2005T polymorphism changes substrate specificity.
    Liu L, Fan L, Peng X, Hu D, Zhou H.
    Cancer Chemother Pharmacol; 2010 Aug 15; 66(3):617-23. PubMed ID: 20309692
    [Abstract] [Full Text] [Related]

  • 12. Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport.
    Kuteykin-Teplyakov K, Luna-Tortós C, Ambroziak K, Löscher W.
    Br J Pharmacol; 2010 Jul 15; 160(6):1453-63. PubMed ID: 20590635
    [Abstract] [Full Text] [Related]

  • 13. A novel MDR1 G1199T variant alters drug resistance and efflux transport activity of P-glycoprotein in recombinant Hek cells.
    Crouthamel MH, Wu D, Yang Z, Ho RJ.
    J Pharm Sci; 2006 Dec 15; 95(12):2767-77. PubMed ID: 16917872
    [Abstract] [Full Text] [Related]

  • 14. Effects of MDR1 1236C > T-2677G > T-3435C > T polymorphisms on the intracellular accumulation of tacrolimus, cyclosporine A, sirolimus and everolimus.
    Wang R, Sun X, Deng YS, Qiu XW.
    Xenobiotica; 2019 Nov 15; 49(11):1373-1378. PubMed ID: 30587068
    [Abstract] [Full Text] [Related]

  • 15. Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo.
    Shi Z, Liang YJ, Chen ZS, Wang XW, Wang XH, Ding Y, Chen LM, Yang XP, Fu LW.
    Cancer Biol Ther; 2006 Jan 15; 5(1):39-47. PubMed ID: 16319528
    [Abstract] [Full Text] [Related]

  • 16. ABCB1 1199G>A genetic polymorphism (Rs2229109) influences the intracellular accumulation of tacrolimus in HEK293 and K562 recombinant cell lines.
    Dessilly G, Elens L, Panin N, Capron A, Decottignies A, Demoulin JB, Haufroid V.
    PLoS One; 2014 Jan 15; 9(3):e91555. PubMed ID: 24621983
    [Abstract] [Full Text] [Related]

  • 17. Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport.
    Takara K, Sakaeda T, Kakumoto M, Tanigawara Y, Kobayashi H, Okumura K, Ohnishi N, Yokoyama T.
    Oncol Res; 2009 Jan 15; 17(11-12):527-33. PubMed ID: 19806783
    [Abstract] [Full Text] [Related]

  • 18. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs.
    Takara K, Tanigawara Y, Komada F, Nishiguchi K, Sakaeda T, Okumura K.
    Biol Pharm Bull; 1999 Dec 15; 22(12):1355-9. PubMed ID: 10746169
    [Abstract] [Full Text] [Related]

  • 19. A novel MDR1 GT1292-3TG (Cys431Leu) genetic variation and its effect on P-glycoprotein biologic functions.
    Crouthamel MH, Wu D, Yang Z, Ho RJ.
    AAPS J; 2010 Dec 15; 12(4):548-55. PubMed ID: 20623213
    [Abstract] [Full Text] [Related]

  • 20. Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.
    De Vera AA, Gupta P, Lei Z, Liao D, Narayanan S, Teng Q, Reznik SE, Chen ZS.
    Cancer Lett; 2019 Feb 01; 442():91-103. PubMed ID: 30391357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.